BioCryst Pharmaceuticals shares owned by UBS O'Connor
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $166k | 33k | 5.08 |
| 2023-09-30 | $1.7M | 242k | 7.08 |
| 2023-06-30 | $1.6M | 233k | 7.04 |
| 2023-03-31 | $1.9M | 226k | 8.34 |
| 2022-12-31 | $2.8M | 245k | 11.48 |
| 2022-09-30 | $2.7M | 216k | 12.60 |
| 2022-06-30 | $2.5M | 236k | 10.58 |
| 2022-03-31 | $712k | 44k | 16.26 |